While our studies on the antitumour potential of ADA activity inhibition have been performed in mice that lack ADA2, which plays a key role in the abolishment of immune surveillance leading to cancer progression, dCF is known to affects both ADA isoenzymes. The gene discussed is ADA2; the disease is cancer.